BioOutsource is the industry leading expert in the biological analysis of biosimilar monoclonal antibodies for the biopharmaceutical industry. We have created a niche within the industry, dedicating ourselves to the biological evaluation of therapeutic antibodies, offering a comprehensive range of off-the-shelf biosimilar testing methodologies to support comparability testing.
With years of experience in the performance of cell based bioassays and a variety of binding assays, coupled with ready to use methods, we provide expertise to reduce both the time and cost of your biosimilar development programmes.
Our clients benefit from our scientific and regulatory insights and our on-going R&D program of assay development.
Our experienced team have developed a suite of off-the-shelf assay packages to complete comparability studies for a range of biosimilar molecules:
- Herceptin (trastuzumab) biosimilar testing
- Rituxan/Mabthera (rituximab) biosimilar testing
- Humira (adalimumab) biosimilar testing
- Enbrel (etanercept) biosimilar testing
- Remicade (infliximab) biosimilar testing
- Avastin (bevacizumab) biosimilar testing
Contact our experts today about your biosimilar testing needs.